Related Experiment Videos

[Sensitivity of the wound microflora of oncological patients to some new antibiotics]

Antibiotiki
|March 1, 1977
PubMed

Insights

Gentamicin demonstrated the highest effectiveness against wound microflora in oncological patients. This antibiotic is suitable for treating mixed bacterial infections and purulent processes before diagnosis.

Area of Science:

  • Microbiology
  • Oncology
  • Infectious Diseases

Background:

  • Wound infections are a significant concern in oncological patients.
  • Understanding antibiotic sensitivity is crucial for effective treatment.
  • Emerging antibiotic resistance necessitates evaluation of new antimicrobial agents.

Purpose of the Study:

  • To assess the sensitivity of wound microflora from oncological patients to several new antibiotics.
  • To identify the most effective antibiotic for treating infections in this patient group.

Main Methods:

  • Laboratory testing of antibiotic sensitivity using the disc diffusion method.
  • Evaluation of 429 bacterial cultures, including Staphylococcus, Enterococcus, Streptococcus, Escherichia, Pseudomonas aeruginosa, and Proteus species.
  • Preparation of antibiotic discs according to WHO guidelines.

Main Results:

  • Gentamicin exhibited the highest activity against all tested microbial species isolated from oncological patient wounds.
  • While generally effective, 16.7% of Enterococcal isolates showed resistance to gentamicin.
  • Monomycin, kanamycin, oxacillin, lincomycin, and macrolides were found to be sufficiently active against pathogenic staphylococci and hemolytic streptococci.

Conclusions:

  • Gentamicin is a highly effective antibiotic for treating polymicrobial infections and empirical treatment of purulent processes in oncological patients.
  • Monitoring gentamicin resistance, particularly in Enterococci, is important.
  • Other tested antibiotics show varying degrees of efficacy against specific pathogens.

Related Concept Videos